Bank of Montreal’s Mateon Therapeutics, Inc. MATN Stock Holding History

Bank of Montreal’s Portfolio MATN Stock Details MATN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-9	Closed	–	–	4318
2016 Q3	$0	Hold	9	–	–	﹤0.01%	4320
2016 Q2	$0	Buy	+9	New	+$6	﹤0.01%	4519

Other funds holding MATN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Bank of Montreal's MATN Position: Q4 2016 in Review

Bank of Montreal sold out of Mateon Therapeutics, Inc. (MATN) in Q4 2016, closing a stake of 9 shares.

Bank of Montreal first reported a position in MATN in Q2 2016 and held it in 2 quarters. The position peaked at $0 in Q3 2016. 1 fund tracked by Wall St. Rank holds MATN as of Q4 2016.

Bank of Montreal reported no remaining Mateon Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
Bank of Montreal sold 9 Mateon Therapeutics, Inc. shares in Q4 2016.
Bank of Montreal first reported a position in Mateon Therapeutics, Inc. in Q2 2016 and held it in 2 quarters.
Bank of Montreal's Mateon Therapeutics, Inc. position peaked at $0 in Q3 2016.
1 fund tracked by Wall St. Rank held Mateon Therapeutics, Inc. as of Q4 2016.

Based on Bank of Montreal's 13F filing for Q4 2016, filed 6 Feb 2017.